News

AddToAny

Google+ Facebook Twitter Twitter

Diagnosing prostate cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour higher-risk cancer in their prostate glands, according to new research.

The study is the first to report that genetic alterations associated with intermediate- and high-risk prostate cancer also may be present in some low-risk cases.

The study found the needle biopsy procedure may miss higher-risk cancer that increases the risk of disease progression. The researchers said that men diagnosed with low-risk cancer may benefit from additional testing for these chromosomal alterations.

George Vasmatzis, lead researcher, said: “We have discovered molecular markers that can help guide men in their decisions about the course of their prostate cancer care.

“We found that the presence of genetic alterations in low-risk cancer can help men decide whether treatment or active surveillance is right for them.”

Picture credit | iStock

Related Articles

Journal-based learning exercises - February 2019

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Download PDF

Breath test to detect cancer

A clinical trial has been launched to see if a breath test could detect the presence of cancer.

One step ahead of cancer

In the UK, one in two of us can expect to get cancer in our lifetimes. With such a high disease burden, efforts to prevent cancer are at least as important as efforts to treat it. 

AI system can identify different cancer cells

Researchers in Japan have shown that an artificial intelligence (AI)-based system can identify different types of cancer cells simply by scanning microscopic images.

Top